Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder
Author:
Affiliation:
1. Department of Neurology; West China Hospital of Sichuan University; Chengdu China
2. Department of Neurology; Third Affiliated Hospital of Sun Yat-sen University; Guangzhou China
Funder
National Natural Science Foundation of China
Department of Science and Technology Research Projects in the Sichuan Province of China
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.13186/fullpdf
Reference25 articles.
1. The clinical course of neuromyelitis optica (Devic's syndrome);Wingerchuk;Neurology,1999
2. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders;Wingerchuk;Neurology,2015
3. Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?;Kim;Mult Scler,2012
4. Failure of natalizumab to prevent relapses in neuromyelitis optica;Kleiter;Arch Neurol,2012
5. Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder;Min;Mult Scler,2012
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Correlation between severe attacks and serum aquaporin-4 antibody titer in neuromyelitis optica spectrum disorder;Journal of Neurology;2024-05-04
2. Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis;Neuromuscular Disorders;2024-05
3. Intruders or protectors – the multifaceted role of B cells in CNS disorders;Frontiers in Cellular Neuroscience;2024-01-10
4. Relapses and Serious Infections in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab: A Swedish Single-Center Study;Journal of Clinical Medicine;2024-01-08
5. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management;Journal of Neurology;2023-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3